CELLOGIC
Desconocido
REBORN: REMODELLING OF THE INFARCTED HEART: PIEZOELECTRIC MULTIFUNCTIONAL PATCH ENABLING THE SEQUENTIAL RELE...
CELLOGIC GMBH
participó en un
HORIZON EUROPE:
HORIZON-CL4-2022-RESILIENCE-01
Cardiac disease remains a major societal and healthcare burden that affect nearly two million European citizens every year.
The REBORN proje...
2022-11-29 - 2026-12-31 | Financiado
2022-11-29 - 2026-12-31 | Financiado
MOZART: MesopOrous matrices for localiZed pH triggered releAse of theRapeuTic ions and drugs
CELLOGIC GMBH
participó en un
H2020:
H2020-NMP-2014-2015
The concept behind MOZART is to develop a library of inorganic nanomatrices to be used as smart platforms for effective, non-invasive and hi...
2015-09-21 - 2019-10-31 | Financiado
2015-09-21 - 2019-10-31 | Financiado
BioCog: Biomarker Development for Postoperative Cognitive Impairment in the Elderly
CELLOGIC GMBH
participó en un
FP7:
Postoperative delirium (POD) is characterized by the progressive deterioration of sensory/cognitive function after surgery with incidences o...
Financiado
Financiado
BIO-DrIM: Personalized minimization of immunosuppression after solid organ transplantation by biomarker driven...
CELLOGIC GMBH
participó en un
FP7:
Organ transplantation has emerged as the gold standard therapy for end-stage organ failure. Incomplete control of chronic allograft injury b...
Financiado
Financiado
* No se disponen de datos de la empresa actual.